Quantum Drug Discovery: What Is Real, What Is Promised
Start with the promise
Drug discovery is expensive, slow and full of late failures. If better simulation could flag a molecule that will be metabolized badly or bind poorly before it reaches clinical trials, that would be valuable. This is why nearly every large pharma company has some quantum effort. See the broader overview in medicine and materials.
Where quantum might truly help
Most drug design uses classical physics-based and AI tools, and they work well. The quantum-hard parts are narrower: accurate energies for metal-containing active sites and some reaction pathways. One flagship example is cytochrome P450, a family of enzymes involved in processing many marketed drugs. An analysis summarized in our sources cites a 2022 estimate (Goings et al.) of about 4,900 logical qubits and roughly one billion Toffoli gates, around 73 hours of runtime, and calls it one of the strongest business cases because it ties to reducing late-stage failures. PsiQuantum and Boehringer Ingelheim researchers reported in a January 2025 preprint overall resource-estimate speedups of 234 times for the P450 heme group and 278 times for FeMoco. PsiQuantum attributes factors of 25.2 and 31.4 within those totals to its Active Volume compilation method, with the rest coming from other algorithm improvements. These are paper estimates for machines that do not exist yet.
Named partnerships
- Boehringer Ingelheim and Google Quantum AI: announced 11 January 2021 as a three-year agreement to research quantum computing in pharmaceutical R&D, with Boehringer setting up a dedicated Quantum Lab. We did not find a published results summary for that term.
- Boehringer Ingelheim and PsiQuantum: PsiQuantum describes work on quantum chemistry for pharmaceuticals and agriculture, including the resource estimates above.
- IBM, Cleveland Clinic and RIKEN: the health system installed an IBM quantum computer for healthcare research. On May 5, 2026, Cleveland Clinic, RIKEN and IBM announced a hybrid quantum-classical simulation of protein complexes of up to 12,635 atoms, which they describe as the largest of its kind on quantum hardware. That is the partners' own description, and it has not been shown to beat the best classical methods.
- IBM and Moderna: a research partnership on mRNA medicine design, including quantum-classical methods for predicting mRNA secondary structure on IBM Heron processors. Results are small research-scale demonstrations checked against classical methods.
Google's molecule experiment
In October 2025 Google reported its Quantum Echoes algorithm on the 105-qubit Willow chip. With UC Berkeley, it studied two molecules, one with 15 atoms and one with 28, in a proof-of-principle linked to nuclear magnetic resonance (NMR), the lab technique chemists use to infer structure. The quantum results matched traditional NMR. Google reports the echo algorithm itself ran 13,000 times faster than the best classical algorithm on a top supercomputer, but that speedup is for the benchmark, not for the molecules. The molecule results were checked against existing NMR, not shown to beat it. Google calls it a step, and says NMR enhanced this way "could become" useful for drug discovery. Coverage noted the manuscript had not yet been independently reviewed at the time. See Google's Willow and Echoes.
What has not been shown
- No drug has been found or designed by a quantum computer.
- No quantum run has beaten the best classical drug-design methods on a real pharma problem.
- Hardware is noisy, and one report says today's devices mostly handle simplified models that classical computers can also handle. See NISQ.
Optimization is a separate story
Some pharma interest is in optimization, such as trial planning and supply chains, rather than chemistry. Those claims are even less settled; see quantum myths for how to read them.
Why to stay excited
The path is concrete. The workflows are being built now, the target enzymes are named, and the hardware roadmaps from IBM, Google and Quantinuum Ltd aim at the 2029 to 2030 range for early fault tolerance. Medicine will not wake up changed overnight, but a field that rehearses early tends to be ready first. For how pilots compare across industries, see the named pilots guide.
Sources and further reading
- PharmaTimes: Boehringer Ingelheim and Google partnership (Jan 2021)
- Google: Quantum Echoes and Willow
- PostQuantum: quantum chemistry, drug discovery and catalysis
- The Quantum Insider: Cleveland Clinic, RIKEN and IBM 12,635-atom protein (May 2026)
- Quantum Computing Report: Moderna and IBM mRNA structure prediction
- Goings et al., cytochrome P450 on classical and quantum computers (arXiv 2202.01244)
- Becker's: Cleveland Clinic and quantum computing
Reported as of 2026-10-09. Resource estimates and timelines change as algorithms improve, and company statements are not independent verification. Check the primary papers. Nothing here is financial advice, and the QNT memecoin is independent of Quantinuum Ltd and of every company named on this page.
Frequently asked questions
Has a quantum computer discovered a drug?
No. Reported work so far involves small molecules, benchmarks and hybrid workflows, none shown to beat the best classical tools.
What is cytochrome P450 and why does it matter?
A family of enzymes involved in processing many medicines. Predicting how drugs interact with it is a costly bottleneck, and a 2022 estimate suggests simulating it would need roughly 4,900 logical qubits.
What did Google's Quantum Echoes show for chemistry?
A proof-of-principle on 15 and 28 atom molecules that matched NMR. The 13,000 times speedup claim applies to the algorithm benchmark, not to the molecules.
Is this investment advice?
No. Nothing here is financial advice, and the QNT memecoin is independent of Quantinuum Ltd and every company named.
Keep reading
- Quantum Computing in Medicine and Materials
How could quantum computers help discover drugs and new materials? A plain English look at quantum simulation, its promise and the current limits. - Google Quantum AI: Willow, Error Correction and Quantum Echoes
What Google's Willow chip and the Quantum Echoes result showed, why below-threshold error correction matters, and what is still unproven. - Quantum Computing Use Cases: What Could It Actually Do?
From drug discovery to logistics and cryptography, here are the realistic use cases of quantum computing. - NISQ Explained: Noisy Intermediate-Scale Quantum Computers
What does NISQ mean? Learn why today's noisy, mid-size quantum computers are limited, what they can do, and how the field plans to move past them.
All Quantum industry, people and AI guides | Back to top | Search the site
Main pages: Quantum computing explained | Quantum and crypto | Companies | Quantum news | Glossary